Dechert and Villey Girard Grolleaud advised Affluent Medical on the deal.
Affluent Medical, a French medtech company specialising in urology and cardiology, executed its IPO on the Euronext Paris regulated market.
Affluent Medical has completed a €25 million capital increase and reached a market capitalisation of €156 million on the day of its listing. These funds will enable Affluent Medical to accelerate the development of its product portfolio.
The Dechert team advising Affluent Medical on Corporate/capital markets with partner Alain Decombe (Picture), special counsel Sophie Lafay and associate Benhouda Derradji; Tax structuring with partner Sabina Comis and associates Etienne Bimbeau and Pierre-Emmanuel Floc’h; IP with national partner Marie Fillon.
Villey Girard Grolleaud advised Affluent Medical with Frédéric Grillier and Adelaïde L’Henaff.
Involved fees earner: Etienne Bimbeau – Dechert; Sabina Comis – Dechert; Alain Decombe – Dechert; Benhouda Derradji – Dechert; Marie Fillon – Dechert; Sophie Lafay – Dechert; Pierre-Emmanuel Floc’h – Eight Advisory; Frédéric Grillier – Villey Girard Grolleaud; Adélaïde L’Henaff – Villey Girard Grolleaud;
Clients: Affluent Medical SA;